Integral Diagnostics Limited
ITGDF
$0.98
-$1.05-51.78%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 56.73% | 51.94% | 52.61% | 49.76% | 9.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.73% | 51.94% | 52.61% | 49.76% | 9.34% |
| Cost of Revenue | 55.25% | 50.50% | 54.92% | 52.02% | 11.44% |
| Gross Profit | 60.05% | 55.16% | 47.84% | 45.07% | 4.88% |
| SG&A Expenses | 54.32% | 49.60% | 48.60% | 45.81% | 6.64% |
| Depreciation & Amortization | 57.99% | 53.16% | 33.62% | 31.11% | 2.96% |
| Other Operating Expenses | 39.40% | 35.14% | 58.52% | 55.56% | -1.49% |
| Total Operating Expenses | 56.03% | 51.26% | 51.82% | 48.98% | 9.71% |
| Operating Income | 64.72% | 59.68% | 60.12% | 57.12% | 5.19% |
| Income Before Tax | 3,551.28% | 3,438.06% | 26.92% | 24.54% | 100.59% |
| Income Tax Expenses | 541.77% | 522.12% | 128.60% | 124.31% | -21.04% |
| Earnings from Continuing Operations | 2,383.18% | 2,312.51% | -16.30% | -17.87% | 99.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2,378.91% | 2,308.29% | -18.65% | -20.17% | 99.41% |
| EBIT | 64.72% | 59.68% | 60.12% | 57.12% | 5.19% |
| EBITDA | 60.07% | 55.18% | 52.49% | 49.64% | 4.00% |
| EPS Basic | 1,680.00% | 1,680.00% | -48.24% | -49.41% | 99.46% |
| Normalized Basic EPS | 322.50% | 314.63% | 24.81% | 22.48% | -180.00% |
| EPS Diluted | 1,660.00% | 1,660.00% | -48.24% | -49.41% | 99.46% |
| Normalized Diluted EPS | 320.00% | 314.63% | 22.48% | 20.16% | -180.00% |
| Average Basic Shares Outstanding | 50.18% | 50.18% | 56.47% | 56.47% | 6.11% |
| Average Diluted Shares Outstanding | 51.44% | 51.44% | 59.55% | 59.55% | 6.11% |
| Dividend Per Share | 33.33% | 28.57% | 17.43% | 14.68% | 0.00% |
| Payout Ratio | 1.08% | 1.08% | 1.09% | 1.09% | -167.69% |